BioCentury
ARTICLE | Emerging Company Profile

Expression: optimizing expression cassettes to solve gene and cell therapy problems

Expression is combining a suite of cell and gene therapy technologies from Emory researchers

March 9, 2022 12:06 AM UTC

With a suite of technologies including a gene therapy expression cassette optimization platform, Expression is tackling some of the biggest challenges facing cell and gene therapies with an initial focus on durability and safety.

First launched as an LLP in Georgia in 2005, Expression Therapeutics Inc. re-launched as a corporation in Delaware in 2019, just before bringing on Mohan Rao as CEO. Rao is a founder of consulting firms Epsilon Economics and Epsilon Life Sciences...